title: Infliximab in the treatment of refractory vasculitis secondary to hepatitis C-associated mixed cryoglobulinaemia.
authors.forename: M-O
authors.initials: MO
authors.lastname: Chandesris
authors.forename: S
authors.initials: S
authors.lastname: Gayet
authors.forename: N
authors.initials: N
authors.lastname: Schleinitz
authors.forename: B
authors.initials: B
authors.lastname: Doudier
authors.forename: J-Robert
authors.initials: JR
authors.lastname: Harlé
authors.forename: G
authors.initials: G
authors.lastname: Kaplanski
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003449:Cryoglobulinemia / Q000150:complications*; D017809:Fatal Outcome; D005260:Female; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D017211:Treatment Failure; D014657:Vasculitis / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D000069285:Infliximab